Impacts of RETN genetic polymorphism on breast cancer development

Chao Qun Wang, Chih Hsin Tang, Huey En Tzeng, Lulu Jin, Jin Zhao, Le Kang, Yan Wang, Gui Nv Hu, Bi Fei Huang, Xiaoni Li, Yong Ming Zhao, Chen Ming Su, Hong Chuan Jin

研究成果: 雜誌貢獻文章同行評審

10 引文 斯高帕斯(Scopus)


The adipokine resistin is linked with obesity, inflammation and various cancers, including breast cancer. This study sought to determine whether certain polymorphisms in the gene encoding resistin, RETN, increase the risk of breast cancer susceptibility. We analyzed levels of resistin expression in breast cancer tissue and samples from The Cancer Genome Atlas database. We also examined associations between four RETN single nucleotide polymorphisms (SNPs; rs3745367, rs7408174, rs1862513 and rs3219175) and breast cancer susceptibility in 515 patients with breast cancer and 541 healthy women without cancer. Compared with wild-type (GG) carriers, those carrying the AG genotype of the RETN SNP rs3219175 and those carrying at least one A allele in the SNP rs3219175 had a higher chance of developing breast cancer (adjusted odds ratio, AOR: 1.295, 95% confidence intervals, CI: 1.065-1.575 and 2.202, 1.701-2.243, respectively). When clinical aspects and the RETN SNP rs7408174 were examined in the breast cancer cohort, the CT genotype was linked to late-stage disease, while women with luminal A disease and at least one C allele were likely to progress to stage III/IV disease and to develop highly pathological grade III disease. Moreover, resistin-positive individuals were at greater risk than resistin-negative individuals for developing pathological grade III disease (OR: 5.020; 95% CI: 1.380-18.259). This study details risk associations between resistin and RETN SNPs in breast cancer susceptibility in Chinese Han women.

頁(從 - 到)2769-2777
期刊Journal of Cancer
出版狀態已發佈 - 1月 1 2020

ASJC Scopus subject areas

  • 腫瘤科


深入研究「Impacts of RETN genetic polymorphism on breast cancer development」主題。共同形成了獨特的指紋。